COVID Testing Kits
Genscript Corporation SARS-CoV-2 Spike 484Q Antibo
SARS-CoV-2 Spike (484Q) Antibody (Q8) mAb Mouse is specific for 484Q site of B 1 617 SARS-CoV-2 This product can recognize single mutant (E484Q) and double mutant (L452R E484Q) but can not recognize the wild type and single mutant (L452R)
Cell Signaling Technology SARS-CoV-2 Spike RBD-ACE2 Blocking Antibody Detection ELISA Kit 20 Kit
SARS-CoV-2 Spike RBD-ACE2 Blocking Antibody Detection ELISA Kit 20 Kit
Maine Molecular Quality Controls Inc QIASTATDX RP SARSCOV2 NEGATIVE
NC3886273 QIASTATDX RP SARSCOV2 NEGATIVE
ATILA BIOSYSTEMS INC iAMP COVID-19 Detection Kit
The iAMP COVID-19 Detection Kit is a real-time reverse transcription isothermal amplification test. The test is based on a proprietary isothermal amplification technology termed OMEGA amplification (Patent: WO 2017/205510 A1; publication: The Journal of Molecular Diagnostics, Vol.22, No 3, 419-428, 2020). OMEGA primer sets are designed to specifically detect RNA and later cDNA from the N and ORF-1ab genes of the SARS-CoV-2 virus in nasal, nasopharyngeal and/or oropharyngeal swabs from patients with signs and symptoms of infection who are suspected of COVID-19. The iAMP COVID-19 assay’s key differentiator from current rRT-PCR COVID-19 assays is its ability to detect SARS-CoV-2 RNA directly from samples without prior RNA extraction process. Swab specimens are inserted directly into our 1X iAMP COVID-19 Sample Buffer Mix with a 15 min incubation at room temperature and can be directly used for OMEGA isothermal amplification and signal detection. Sample to result takes about 1 hour.
Sino Biological SARS-COV-2 KP.2 (Omicron) Spike S1+S2 trimer Protein (ECD, His Tag), Endotoxin-Free
A DNA sequence encoding the SARS-CoV-2 (KP.2) Spike S1+S2 (YP_009724390.1, with mutations ins16MPLF, T19I, R21T, L24del, P25del, P26del, A27S, S50L, H69del, V70del, V127F, G142D, Y144del, F157S, R158G, N211del, L212I, V213G, L216F, H245N, A264D, I332V, G339H, R346T, K356T, S371F, S373P, S375F, T376A, R403K, D405N, R408S, K417N, N440K, V445H, G446S, N450D, L452W, L455S, F456L, N460K, S477N, T478K, N481K, V483del, E484K, F486P, Q498R, N501Y, Y505H, E554K, A570V, D614G, P621S, H655Y, N679K, P681R, N764K, D796Y, F817P, A892P, A899P, S939F, A942P, Q954H, N969K, K986P, V987P, V1104L, P1143L and furin cleavage site mutants) expressed with the bacteriophage T4 fibritin and a polyhistidine tag at the C-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant KP.2).
Sino Biological SARS-COV-2 KP.2 (Omicron) Spike S1+S2 trimer Protein (ECD, His Tag), Endotoxin-Free
A DNA sequence encoding the SARS-CoV-2 (KP.2) Spike S1+S2 (YP_009724390.1, with mutations ins16MPLF, T19I, R21T, L24del, P25del, P26del, A27S, S50L, H69del, V70del, V127F, G142D, Y144del, F157S, R158G, N211del, L212I, V213G, L216F, H245N, A264D, I332V, G339H, R346T, K356T, S371F, S373P, S375F, T376A, R403K, D405N, R408S, K417N, N440K, V445H, G446S, N450D, L452W, L455S, F456L, N460K, S477N, T478K, N481K, V483del, E484K, F486P, Q498R, N501Y, Y505H, E554K, A570V, D614G, P621S, H655Y, N679K, P681R, N764K, D796Y, F817P, A892P, A899P, S939F, A942P, Q954H, N969K, K986P, V987P, V1104L, P1143L and furin cleavage site mutants) expressed with the bacteriophage T4 fibritin and a polyhistidine tag at the C-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant KP.2).
Sino Biological SARS-CoV-2 B.1.1.529 (Omicron) S1+S2 trimer Protein ( ECD, His Tag) (HPLC-verified), Endotoxin-Free
A DNA sequence encoding the SARS-CoV-2 Spike S1+S2 (YP_009724390.1, with mutations A67V, HV69-70 deletion, T95I, G142D, VYY143-145 deletion, N211 deletion, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, F817P, N856K, A892P, A899P, A942P, Q954H, N969K, L981F, K986P, V987P and furin cleavage site mutants) expressed with the bacteriophage T4 fibritin and a polyhistidine tag at the C-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant B.1.1.529) which emerged in the South Africa.
Sino Biological SARS-CoV-2 JN.1 (Omicron) Spike S1+S2 trimer Protein (ECD, His Tag)(HPLC-verified), Endotoxin-Free
A DNA sequence encoding the SARS-CoV-2 (JN.1) Spike S1+S2 (YP_009724390.1, with mutations ins16MPLF, T19I, R21T, L24del, P25del, P26del, A27S, S50L, H69del, V70del, V127F, G142D, Y144del, F157S, R158G, N211del, L212I, V213G, L216F, H245N, A264D, I332V, G339H, K356T, S371F, S373P, S375F, T376A, R403K, D405N, R408S, K417N, N440K, V445H, G446S, N450D, L452W, L455S, N460K, S477N, T478K, N481K, V483del, E484K, F486P, Q498R, N501Y, Y505H, E554K, A570V, D614G, P621S, H655Y, N679K, P681R, N764K, D796Y, F817P, A892P, A899P, S939F, A942P, Q954H, N969K, K986P, V987P, P1143L and furin cleavage site mutants) expressed with the bacteriophage T4 fibritin and a polyhistidine tag at the C-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant JN.1).
Sino Biological SARS-CoV-2 (BA.4/BA.5/BA.5.2) Spike S1+S2 trimer Protein (ECD, His Tag) (HPLC-verified), Endotoxin-Free
A DNA sequence encoding the SARS-CoV-2 (BA.4/BA.5/BA.5.2) Spike S1+S2 (YP_009724390.1, with mutations F817P, A892P, A899P, A942P, K986P, V987P, T19I, L24del, P25del, P26del, A27S, H69del, V70del, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K and furin cleavage site mutants) expressed with the bacteriophage T4 fibritin and a polyhistidine tag at the C-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant BA.4/BA.5/BA.5.2).
Bioss SARS-CoV-2 S-Protein ACE2 Bind
SARS-CoV-2 S-Protein ACE2 Binding Domain Primary Antibody Unconjugated Host Species Mouse Target Species SARS-CoV-2 Clonality Monoclonal Applications WB 2G1Concentration Lot Dependent Size 100 ul Storage Buffer PBS 50% glycerol and 5 mm NaN3
Revvity Health Sciences Inc HTRF Human and Mouse Phospho-RET (pan) Detection Kit, 500 Assay Points
HTRF Human and Mouse Phospho-RET (pan) Detection Kit, 500 Assay Points
Epigentek Inc CoviDrop SARS-CoV-2 Targeted Proprotein Convertase Inhibitor Screening Fast Kit (96 Assays)
For high throughput screening of compounds that inhibit the proprotein convertase cleavage of SARS-CoV-2
Epigentek Inc CoviDrop SARS-CoV-2 Targeted Proprotein Convertase Activity/Inhibition Assay Kit (48 Assays)
For high throughput measurement of SARS-CoV-2 proprotein convertase cleavage inhibition from human samples
Medchemexpress LLC SARS-CoV-2 spike receptor-binding domain (Omicron, B.1.1.529) | >95.0% | 10 UG
Recombinant SARS-CoV-2 spike receptor-binding domain (Omicron B.1.1.529), expressed in mammalian cells and purified for use in biochemical and immunological assays. The protein carries a C-terminal His tag, is supplied as a sterile, filtered PBS solution, and is intended for applications such as ELISA, binding studies, and antibody characterization.
- Expressed in HEK293 cells with a C-terminal His tag.
- Represents the Omicron (B.1.1.529) variant of the spike RBD.
- Purity greater than 95% by reducing SDS-PAGE.
- Supplied as a 0.22 μm filtered PBS solution, pH 7.4.
- Store at -80°C; shipped on dry ice; avoid repeated freeze-thaw cycles.
- Suitable for ELISA, binding assays, and antibody characterization.